The Long-term Cardiac Benefits of β-Blockers After Coronary Bypass: Questioned but Not Disproven

Ann Thorac Surg. 2021 Jan;111(1):75-76. doi: 10.1016/j.athoracsur.2020.05.023. Epub 2020 Jun 18.

Authors

Eric W Etchill¹, Glenn J R Whitman²

Affiliations

¹ Department of Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland.
² Division of Cardiac Surgery, Department of Surgery, Johns Hopkins School of Medicine, Zayed Tower, Ste 7107, 1800 Orleans St, Baltimore, MD 21287. Electronic address: gwhitman@jhmi.edu.

PMID: 32565084
DOI: 10.1016/j.athoracsur.2020.05.023

No abstract available

Publication types

Comment

MeSH terms

Adrenergic beta-Antagonists* / therapeutic use
Coronary Artery Bypass*
Heart
Humans

Substances

Adrenergic beta-Antagonists